Literature DB >> 10772044

Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves.

A Roy1, N J Brand, M H Yacoub.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Severe heart valve disorder has been reported in patients receiving a combination of the anorectic drugs fenfluramine and phentermine. The exact molecular mechanisms involved remain unknown. Fenfluramine alters the serotonin level in the brain, while phentermine interferes with the pulmonary clearance of serotonin; these data suggest that serotonin levels affect regulation of valve function. The aim of the present study was to characterize the serotonin receptor (5-hydroxytryptamine) subtypes expressed in the interstitial cells of human heart valves.
METHODS: Interstitial cells were isolated and cultured from the aortic, pulmonary, mitral and tricuspid valves of recipient hearts obtained during transplantation. Total RNA was extracted from cultured cells in order to determine gene expression by reverse transcription-polymerase chain reaction (RT-PCR) using 5-hydroxytryptamine (5-HT) subtype-specific primer pairs.
RESULTS: The results show that: (i) 5-HT 1B and 1D receptor subtypes are expressed in all four heart valves. This is significant as the 1B and 1D receptor subfamilies are the target of the anti-migraine drug sumatriptan, and these receptors regulate cardiac function and movement; (ii) 5-HT 1A, 5-HT 1E and 5-HT 1F are not expressed in interstitial cells isolated from the valves.
CONCLUSION: We conclude that preliminary evidence exists for the presence of distinct subsets of 5-HT receptors in human heart valves, indicating that interstitial cells of the valves potentially respond to serotonin levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772044

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  7 in total

1.  Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Authors:  Jie Xu; Bo Jian; Richard Chu; Zhibin Lu; Quanyi Li; John Dunlop; Sharon Rosenzweig-Lipson; Paul McGonigle; Robert J Levy; Bruce Liang
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

Authors:  Bo Jian; Jie Xu; Jeanne Connolly; Rashmin C Savani; Navneet Narula; Bruce Liang; Robert J Levy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Direct influence of serotonin on the larval heart of Drosophila melanogaster.

Authors:  Sameera Dasari; Robin L Cooper
Journal:  J Comp Physiol B       Date:  2005-12-14       Impact factor: 2.200

Review 4.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

5.  Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.

Authors:  W Kocha; J Maroun; H Kennecke; C Law; P Metrakos; J F Ouellet; R Reid; C Rowsell; A Shah; S Singh; S Van Uum; R Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

6.  Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors.

Authors:  Deidi Strickland Bergestuen; Jørgen Gravning; Kristina Hermann Haugaa; Laura G Sahakyan; Svend Aakhus; Espen Thiis-Evensen; Erik Øie; Pål Aukrust; Håvard Attramadal; Thor Edvardsen
Journal:  BMC Cancer       Date:  2010-01-06       Impact factor: 4.430

7.  The genetic consequences of dog breed formation-Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels.

Authors:  Erik Axelsson; Ingrid Ljungvall; Priyasma Bhoumik; Laura Bas Conn; Eva Muren; Åsa Ohlsson; Lisbeth Høier Olsen; Karolina Engdahl; Ragnvi Hagman; Jeanette Hanson; Dmytro Kryvokhyzha; Mats Pettersson; Olivier Grenet; Jonathan Moggs; Alberto Del Rio-Espinola; Christian Epe; Bruce Taillon; Nilesh Tawari; Shrinivas Mane; Troy Hawkins; Åke Hedhammar; Philippe Gruet; Jens Häggström; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2021-09-02       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.